Provenance
Written by SPS and the College of Sexual and Reproductive Healthcare (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
Patient Group Directions, Templates, Reproductive health
- Lidocaine injection for subdermal etonogestrel in contraception
- Combined hormonal contraceptive transdermal patch
- Progestogen only pill (POP) for contraception
- Combined oral hormonal contraceptive (COC) in reproductive health
- Ulipristal acetate 30mg tablets for emergency contraception
- Levonorgestrel 1500 microgram tablets for emergency contraception
- Medroxyprogesterone acetate (SC-DMPA) injection for contraception
- Lidocaine plus prilocaine cream for IUD insertion or removal
- Medroxyprogesterone acetate (DMPA) IM injection for contraception
- Lidocaine 10mg/ml spray for IUD insertion or removal
- Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
- Etonogestrel (e.g. Nexplanon®) implant for contraception
- Copper Intrauterine Device (Cu-IUD)
Update history
- V2.0 PGD template removed as expired. Explanatory wording regarding versions of PGD template removed.
- V3.1 template updated to correct typo
- Revised template published to reflect minor clarifications following feedback.
- Version 3.1 published
- Planned review detail added
- Republished
- Version 3.0 template published and explanatory wording added. Page reviewed.
- Information added regarding name change of FSRH to CoSRH
- Title, URL and summary amended.
- Version 1 removed as expiring end March '23
- Version 2.0 PGD template added
- Revised template added to reflect updated FSRH guidance on use of e-cigarettes/vaping and minor detailed changes
- Published